- Report
- April 2025
- 150 Pages
Global
From €2856EUR$3,250USD£2,463GBP
€4262EUR$4,850USD£3,676GBP
- Report
- April 2025
- 150 Pages
Global
From €2856EUR$3,250USD£2,463GBP
€4262EUR$4,850USD£3,676GBP
- Report
- March 2025
- 150 Pages
Global
From €2856EUR$3,250USD£2,463GBP
€4262EUR$4,850USD£3,676GBP
- Report
- March 2025
- 150 Pages
Global
From €2856EUR$3,250USD£2,463GBP
€4262EUR$4,850USD£3,676GBP
- Report
- March 2025
- 150 Pages
Global
From €2856EUR$3,250USD£2,463GBP
€4262EUR$4,850USD£3,676GBP
- Report
- March 2025
- 150 Pages
Global
From €2856EUR$3,250USD£2,463GBP
€4262EUR$4,850USD£3,676GBP
- Report
- July 2025
- 220 Pages
Global
From €5140EUR$5,850USD£4,434GBP
- Report
- July 2025
- 406 Pages
Global
From €5140EUR$5,850USD£4,434GBP
- Report
- July 2025
- 486 Pages
Global
From €5140EUR$5,850USD£4,434GBP
- Report
- July 2025
- 388 Pages
Global
From €5140EUR$5,850USD£4,434GBP
- Report
- July 2025
- 387 Pages
Global
From €5140EUR$5,850USD£4,434GBP
- Report
- July 2025
- 380 Pages
Global
From €5140EUR$5,850USD£4,434GBP
- Report
- July 2025
- 568 Pages
Global
From €5140EUR$5,850USD£4,434GBP
- Report
- July 2025
- 281 Pages
Global
From €5140EUR$5,850USD£4,434GBP
- Report
- July 2025
- 395 Pages
Global
From €5140EUR$5,850USD£4,434GBP
- Report
- July 2025
- 469 Pages
Global
From €5140EUR$5,850USD£4,434GBP
- Report
- July 2025
- 287 Pages
Global
From €5140EUR$5,850USD£4,434GBP
- Report
- July 2025
- 359 Pages
Global
From €5140EUR$5,850USD£4,434GBP
- Report
- July 2025
- 281 Pages
Global
From €5140EUR$5,850USD£4,434GBP
- Report
- July 2025
- 368 Pages
Global
From €5140EUR$5,850USD£4,434GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more